# ACRYSOF® Restor Apodized Diffractive IOL Postmarket Evaluation of Clinical Outcomes and Life-Style Visual Performance RESTOR IOL SN60WF IOL (Control Group)

> **NCT00345111** · PHASE4 · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Refractive Assessment

## Interventions

- **PROCEDURE:** Clinical visual outcomes of bilateral implantation of Restore Intra Ocular Lens.

## Key facts

- **NCT ID:** NCT00345111
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-07
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Verified with former investigator that recruitment activity did not take place
- **Last updated:** 2018-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00345111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00345111, "ACRYSOF® Restor Apodized Diffractive IOL Postmarket Evaluation of Clinical Outcomes and Life-Style Visual Performance RESTOR IOL SN60WF IOL (Control Group)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00345111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*